Updated Jul 16, 2026
PALEKAR ROHAN is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $123K.
Rohan Palekar is the Chief Executive Officer of 89bio, Inc., a biotechnology company focused on developing therapies for liver and metabolic diseases. He has held this position and has been involved in multiple SEC filings related to the company.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-10-31 | ETNB | 89bio, Inc. | J — Other acquisition / disposition | 934.3K | — | |
| 2025-10-31 | ETNB | 89bio, Inc. | A — Grant or award | 125.0K | $0.00 | |
| 2025-08-01 | ETNB | 89bio, Inc. | F — Tax withholding / forfeiture | 55.8K | $9.16 | $511K |
| 2024-12-10 | ETNB | 89bio, Inc. | P — Open-market purchase | 5.0K | $7.89 | $39K |
| 2024-11-25 | ETNB | 89bio, Inc. | P — Open-market purchase | 10.0K | $8.35 | $84K |
Rohan Palekar is the Chief Executive Officer of 89bio, Inc., a biotechnology company focused on developing therapies for liver and metabolic diseases. He has held this position and has been involved in multiple SEC filings related to the company.…
Recorded transactions: 2 open-market purchases ($123K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live PALEKAR ROHAN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.